Exforge HCT
Active substance: valsartan, hydrochlorothiazide, amlodipine besilate
valsartan, hydrochlorothiazide, amlodipine besilate
Centralised EU authorisationActive
Marketing holder: Novartis Europharm Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Products containing valsartan in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| US 423 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-29af-7079-b0db-c9a33a62cd49,01a1208c-2ba5-75cf-992d-cf9fee14e9aa,01a1208c-2d7a-75b1-95d8-a7cc04d38e1d,01a1208c-4f53-7977-a9fa-a880fbb1ccb5,01a1208c-6a7e-7bd0-a7c4-9fd98e75485c;count=140 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/001068
- Registration status
- Active
- ATC code
- C09DX01
Sources
- product · EMA · EMEA/H/C/001068 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/001068 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/001068 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/001068 · Verified 2026-10-09
- ingredients.2 · EMA · EMEA/H/C/001068 · Verified 2026-10-09